Back to McKinsey Chart of the Day

Vaccination programs plunge ahead

COVID-19 vaccine stocks are building in the EU, UK, and US. The US will likely soon have sufficient supplies for all adults; the others are not far behind.

Vaccines should be available for most adults in the European Union, United Kingdom, and United States, but timing varies.
We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: McKinsey_Website_Accessibility@mckinsey.com

To read the article, see “When will the COVID-19 pandemic end?,” March 26, 2021.